Pet Cancer Therapeutics Market Explore Future Growth 2017-2025 by Global Top Players - Aratana Therapeutics, AB Science, Boehinger Ingelheim International GmbH, Zenoaq, Morphogenesis, VetDC, Karyopharm Therapeutics, Regeneus, Rhizen Pharmaceuticals SA, Oa

Coherent Market Insights has announced the addition of the “Pet Cancer Therapeutics Market Size Status and Forecast 2026”, The report classifies the global Pet Cancer Therapeutics Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.

This report studies the global Pet Cancer Therapeutics Speaker market, analyzes and researches the Pet Cancer Therapeutics Speaker development status and forecast in North America, Europe, Asia Pacific, Latin America and Rest of the World. This report focuses on the top players in global market, like
Aratana Therapeutics, AB Science, Boehinger Ingelheim International GmbH, Zenoaq, Morphogenesis, VetDC, Karyopharm Therapeutics, Regeneus, Rhizen Pharmaceuticals SA, Oasmia Pharmaceuticals AB, Zoetis

Request sample a copy: https://www.coherentmarketinsights.com/insight/request-sample/1284

The pet cancer therapeutics include chemotherapy drugs, targeted therapies, combination therapies, and immunotherapy vaccines, which are commonly recommended by the veterinary doctors. The drugs are mostly recommended to treat various conditions such as lymphoma, mast cell tumors, fibrosarcoma, hemangiosarcoma, and others. Currently, a wide range of formulations are available in the global market for the treatment of pet cancers, which can be administered in the form of tablets, injections or can be applied topically. Thus, the large variety of treatment options has made it easy for the pets to receive effective cancer treatment suitable to curb the condition.

The major factor driving growth of the pet cancer therapeutics market include robust number of pipeline drugs for the treatment of highly prevalent conditions such as lymphoma and melanoma. For instance, in 2017, Aratana Therapeutics received approval from the United States Department of Agriculture (USDA) Center for Veterinary Biologics for canine osteosarcoma vaccine- AT-014 for the treatment of dogs diagnosed with osteosarcoma, one year of age or older. The drug candidate was licensed exclusively from Advaxis, Inc. and is currently in the pivotal trial. Moreover, the private and government organizations such as Veterinary Cancer Society, Petco Foundation, and Animal Cancer Foundation are working together to formulate novel drugs for dogs and cats, which is a major factor expected to propel growth of the pet cancer therapeutics market over the forecast period. However, lack of awareness regarding pet diseases, high cost, and adverse effects of the drugs are the factors restraining pet cancer therapeutics market growth.

Global Pet Cancer Therapeutics Market, By Therapy Type:

Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy

Global Pet Cancer Therapeutics Market, By Pet Type:

Cat
Dog
Horse

Global Pet Cancer Therapeutics Market, By Mode of Administration:

Oral
Intravenous
Topical

Global Pet Cancer Therapeutics Market, By Application:

Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others

Increasing prevalence of cancer indicates a need to adopt approved novel therapies, which are proved to be highly effective for the treatment of cancers in pets, thus, augmenting the pet cancer therapeutics market growth during the forecast period. According to the study by Fetch a Cure, 2015, dogs and cats have a higher incidence of tumors than humans, where dogs are 35 times more likely to develop skin cancer, 4 times more likely to develop breast tumors, and 8 times more likely to develop bone cancer. According to the study published by Animal Cancer Foundation, 2017, approximately around 25% of all dogs will develop a tumor at some point in their life. Furthermore, increasing number of relapsed cancer rates and the availability of relapsed/ refractory therapeutics integrated with veterinarian recommendation is expected to additionally generate the revenue for the market players.

Else place an Inquire before Purchase “Pet Cancer Therapeutics Market Size, Status and Forecast 2025 : https://www.coherentmarketinsights.com/insight/talk-to-analyst/1284

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.